Posttranscriptional deregulation of Src due to aberrant miR34a and miR203 contributes to gastric cancer development |
Hao, Qiang
(The State Key Laboratory of Cancer Biology, School of Pharmacy, Department of Biopharmaceutics, The Fourth Military Medical University)
Lu, Xiaozhao (Department of Nephrology, The 323 Hospital of PLA) Liu, Nannan (The Preclinical Medical Teaching Experiment Center, School of Basic Medical Sciences, The Fourth Military Medical University) Xue, Xiaochang (The State Key Laboratory of Cancer Biology, School of Pharmacy, Department of Biopharmaceutics, The Fourth Military Medical University) Li, Meng (The State Key Laboratory of Cancer Biology, School of Pharmacy, Department of Biopharmaceutics, The Fourth Military Medical University) Zhang, Cun (The State Key Laboratory of Cancer Biology, School of Pharmacy, Department of Biopharmaceutics, The Fourth Military Medical University) Qin, Xin (The State Key Laboratory of Cancer Biology, School of Pharmacy, Department of Biopharmaceutics, The Fourth Military Medical University) Li, Weina (The State Key Laboratory of Cancer Biology, School of Pharmacy, Department of Biopharmaceutics, The Fourth Military Medical University) Shu, Zhen (The State Key Laboratory of Cancer Biology, School of Pharmacy, Department of Biopharmaceutics, The Fourth Military Medical University) Song, Bin (Department of Urology, Tangdu Hospital, The Fourth Military Medical University) Wang, Qing (Department of General Surgery, Tangdu Hospital, The Fourth Military Medical University) Song, Liqiang (Department of Respiratory Medicine, Xijing Hospital, The Fourth Military Medical University) Zhang, Wei (The State Key Laboratory of Cancer Biology, School of Pharmacy, Department of Biopharmaceutics, The Fourth Military Medical University) Zhang, Yingqi (The State Key Laboratory of Cancer Biology, School of Pharmacy, Department of Biopharmaceutics, The Fourth Military Medical University) |
1 | Li, N., Tang, B., Zhu, E. D., Li, B. S., Zhuang, Y., Yu, S., Lu, D. S., Zou, Q. M., Xiao, B. and Mao, X. H. (2012) Increased miR-222 in H. pylori-associated gastric cancer correlated with tumor progression by promoting cancer cell proliferation and targeting RECK. FEBS Lett. 586, 722-728. DOI ScienceOn |
2 | Zauli, G., Voltan, R., di Iasio, M. G., Bosco, R., Melloni, E., Sana, M. E. and Secchiero, P. (2011) miR-34a induces the downregulation of both E2F1 and B-Myb oncogenes in leukemic cells. Clin. Cancer Res. 17, 2712-2724. DOI |
3 | Yang, G., Lu, X., Wang, L., Bian, Y., Fu, H., Wei, M., Pu, J., Jin, L., Yao, L. and Lu, Z. (2011) E2F1 and RNA binding protein QKI comprise a negative feedback in the cell cycle regulation. Cell Cycle 10, 2703-2713. DOI |
4 | Oukka, M., Wein, M. N. and Glimcher, L. H. (2004) Schnurri-3 (KRC) interacts with c-Jun to regulate the IL-2 gene in T cells. J. Exp. Med. 199, 15-24. DOI |
5 | Wightman, B., Ha, I. and Ruvkun, G. (1993) Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Cell 75, 855-862. DOI ScienceOn |
6 | Lee, R. C., Feinbaum, R. L. and Ambros, V. (1993) The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75, 843-854. DOI ScienceOn |
7 | Bartel, D. P. (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281-297. DOI ScienceOn |
8 | Calin, G. A. and Croce, C. M. (2006) MicroRNA signatures in human cancers. Nat. Rev. Cancer 6, 857-866. DOI ScienceOn |
9 | Esquela-Kerscher, A. and Slack, F. J. (2006) Oncomirs - microRNAs with a role in cancer. Nat. Rev. Cancer 6, 259-269. DOI ScienceOn |
10 | Kato, M., Paranjape, T., Muller, R. U., Nallur, S., Gillespie, E., Keane, K., Esquela-Kerscher, A., Weidhaas, J. B. and Slack, F. J. (2009) The mir-34 microRNA is required for the DNA damage response in vivo in C. elegans and in vitro in human breast cancer cells. Oncogene 28, 2419-2424. DOI ScienceOn |
11 | Roy, S., Levi, E., Majumdar, A. P. and Sarkar, F. H. (2012) Expression of miR-34 is lost in colon cancer which can be re-expressed by a novel agent CDF. J. Hematol. Oncol. 5, 58. DOI |
12 | Kasinski, A. L. and Slack, F. J. (2012) miRNA-34 prevents cancer initiation and progression in a therapeutically-resistant K-ras and p53-induced mouse model of lung adenocarcinoma. Cancer Res. 72, 5576-5587. DOI |
13 | Wang, C., Zheng, X., Shen, C. and Shi, Y. (2012) MicroRNA- 203 suppresses cell proliferation and migration by targeting BIRC5 and LASP1 in human triple-negative breast cancer cells. J. Exp. Clin. Cancer Res. 31, 58. DOI |
14 | Summy, J. M. and Gallick, G. E. (2003) Src family kinases in tumor progression and metastasis. Cancer Metastasis Rev. 22, 337-358. DOI ScienceOn |
15 | Okamoto, W., Okamoto, I., Yoshida, T., Okamoto, K., Takezawa, K., Hatashita, E., Yamada, Y., Kuwata, K., Arao, T., Yanagihara, K., Fukuoka, M., Nishio, K. and Nakagawa, K. (2010) Identification of c-Src as a potential therapeutic target for gastric cancer and of MET activation as a cause of resistance to c-Src inhibition. Mol. Cancer Ther. 9, 1188-1197. DOI |
16 | Siegel, R., Naishadham, D. and Jemal, A. (2012) Cancer statistics, 2012. CA Cancer J. Clin. 62, 10-29. DOI ScienceOn |
17 | Grimson, A., Farh, K. K., Johnston, W. K., Garrett-Engele, P., Lim, L. P. and Bartel, D. P. (2007) MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol. Cell 27, 91-105. DOI ScienceOn |
18 | Garofalo, M., Romano, G., Di Leva, G., Nuovo, G., Jeon, Y. J., Ngankeu, A., Sun, J., Lovat, F., Alder, H., Condorelli, G., Engelman, J. A., Ono, M., Rho, J. K., Cascione, L., Volinia, S., Nephew, K. P. and Croce, C. M. (2012) EGFR and MET receptor tyrosine kinase-altered microRNA expression induces tumorigenesis and gefitinib resistance in lung cancers. Nat. Med. 18, 74-82. DOI |
19 | Saini, S., Arora, S., Majid, S., Shahryari, V., Chen, Y., Deng, G., Yamamura, S., Ueno, K. and Dahiya, R. (2011) Curcumin modulates microRNA-203-mediated regulation of the Src-Akt axis in bladder cancer. Cancer Prev. Res. (Phila) 4, 1698-1709. DOI ScienceOn |
20 | Le, X. F. and Bast, R. C. Jr. (2011) Src family kinases and paclitaxel sensitivity. Cancer Biol. Ther. 12, 260-269. DOI |
21 | Aleshin, A. and Finn, R. S. (2010) SRC: a century of science brought to the clinic. Neoplasia 12, 599-607. DOI |
22 | Wheeler, D. L., Iida, M. and Dunn, E. F. (2009) The role of Src in solid tumors. Oncologist 14, 667-678. DOI ScienceOn |
23 | Ishizawar, R. and Parsons, S. J. (2004) c-Src and cooperating partners in human cancer. Cancer Cell 6, 209-214. DOI ScienceOn |
24 | Yang, G., Fu, H., Zhang, J., Lu, X., Yu, F., Jin, L., Bai, L., Huang, B., Shen, L., Feng, Y., Yao, L. and Lu, Z. (2010) RNA-binding protein quaking, a critical regulator of colon epithelial differentiation and a suppressor of colon cancer. Gastroenterology 138, 231-240, e231-235. DOI ScienceOn |